CA2571932A1 - Multimodal method for identifying hazardous agents - Google Patents
Multimodal method for identifying hazardous agents Download PDFInfo
- Publication number
- CA2571932A1 CA2571932A1 CA002571932A CA2571932A CA2571932A1 CA 2571932 A1 CA2571932 A1 CA 2571932A1 CA 002571932 A CA002571932 A CA 002571932A CA 2571932 A CA2571932 A CA 2571932A CA 2571932 A1 CA2571932 A1 CA 2571932A1
- Authority
- CA
- Canada
- Prior art keywords
- raman
- sample
- entities
- optical property
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 143
- 231100001261 hazardous Toxicity 0.000 title claims abstract description 91
- 238000001069 Raman spectroscopy Methods 0.000 claims abstract description 160
- 230000003287 optical effect Effects 0.000 claims abstract description 130
- 239000003795 chemical substances by application Substances 0.000 claims description 126
- 230000005855 radiation Effects 0.000 claims description 73
- 238000001514 detection method Methods 0.000 claims description 58
- 239000000126 substance Substances 0.000 claims description 54
- 230000003595 spectral effect Effects 0.000 claims description 52
- 239000000758 substrate Substances 0.000 claims description 35
- 238000001228 spectrum Methods 0.000 claims description 31
- 239000004973 liquid crystal related substance Substances 0.000 claims description 28
- 238000003384 imaging method Methods 0.000 claims description 24
- 239000002245 particle Substances 0.000 claims description 16
- 239000000835 fiber Substances 0.000 claims description 15
- 230000001678 irradiating effect Effects 0.000 claims description 12
- 238000000386 microscopy Methods 0.000 claims description 12
- 230000010287 polarization Effects 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 9
- 239000003570 air Substances 0.000 claims description 9
- 239000012080 ambient air Substances 0.000 claims description 9
- 238000000799 fluorescence microscopy Methods 0.000 claims description 8
- 241000700605 Viruses Species 0.000 claims description 6
- 238000002835 absorbance Methods 0.000 claims description 6
- 230000000007 visual effect Effects 0.000 claims description 5
- 230000005540 biological transmission Effects 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 231100000765 toxin Toxicity 0.000 claims description 4
- 239000003131 biological toxin Substances 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims description 3
- 239000013307 optical fiber Substances 0.000 claims description 3
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 claims description 2
- 239000004038 photonic crystal Substances 0.000 claims description 2
- 238000004626 scanning electron microscopy Methods 0.000 claims description 2
- 238000010183 spectrum analysis Methods 0.000 abstract description 10
- 239000000523 sample Substances 0.000 description 248
- 238000004458 analytical method Methods 0.000 description 93
- 238000000701 chemical imaging Methods 0.000 description 33
- 238000005070 sampling Methods 0.000 description 28
- 239000000463 material Substances 0.000 description 27
- 238000005286 illumination Methods 0.000 description 26
- 238000001237 Raman spectrum Methods 0.000 description 24
- 238000004611 spectroscopical analysis Methods 0.000 description 22
- 210000004215 spore Anatomy 0.000 description 22
- 238000005516 engineering process Methods 0.000 description 21
- 230000009102 absorption Effects 0.000 description 20
- 238000010521 absorption reaction Methods 0.000 description 19
- 239000000306 component Substances 0.000 description 17
- 230000000875 corresponding effect Effects 0.000 description 17
- 238000005259 measurement Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 244000063299 Bacillus subtilis Species 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 241000193738 Bacillus anthracis Species 0.000 description 9
- 230000005284 excitation Effects 0.000 description 9
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 9
- 238000003332 Raman imaging Methods 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 238000002189 fluorescence spectrum Methods 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 230000000877 morphologic effect Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 235000014469 Bacillus subtilis Nutrition 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000012491 analyte Substances 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000002073 fluorescence micrograph Methods 0.000 description 6
- 238000001506 fluorescence spectroscopy Methods 0.000 description 6
- 229910000530 Gallium indium arsenide Inorganic materials 0.000 description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 238000000513 principal component analysis Methods 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 239000010703 silicon Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 241001465318 Aspergillus terreus Species 0.000 description 4
- 241000194103 Bacillus pumilus Species 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 238000007405 data analysis Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000004020 luminiscence type Methods 0.000 description 4
- 230000000873 masking effect Effects 0.000 description 4
- 229910052753 mercury Inorganic materials 0.000 description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 230000002123 temporal effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- KXNLCSXBJCPWGL-UHFFFAOYSA-N [Ga].[As].[In] Chemical compound [Ga].[As].[In] KXNLCSXBJCPWGL-UHFFFAOYSA-N 0.000 description 3
- 238000004847 absorption spectroscopy Methods 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 229940065181 bacillus anthracis Drugs 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 210000004666 bacterial spore Anatomy 0.000 description 3
- 239000003124 biologic agent Substances 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000013043 chemical agent Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000013480 data collection Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000014103 egg white Nutrition 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000012921 fluorescence analysis Methods 0.000 description 3
- 239000005350 fused silica glass Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000010191 image analysis Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 229910001507 metal halide Inorganic materials 0.000 description 3
- 150000005309 metal halides Chemical class 0.000 description 3
- 239000003068 molecular probe Substances 0.000 description 3
- 238000000399 optical microscopy Methods 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 239000010453 quartz Substances 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 239000010937 tungsten Substances 0.000 description 3
- -1 tungsten halogen Chemical class 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 241001466538 Gymnogyps Species 0.000 description 2
- 229910000661 Mercury cadmium telluride Inorganic materials 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000013626 chemical specie Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 238000004476 mid-IR spectroscopy Methods 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- ZXEYZECDXFPJRJ-UHFFFAOYSA-N $l^{3}-silane;platinum Chemical compound [SiH3].[Pt] ZXEYZECDXFPJRJ-UHFFFAOYSA-N 0.000 description 1
- 241000588624 Acinetobacter calcoaceticus Species 0.000 description 1
- 241000710929 Alphavirus Species 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 206010006500 Brucellosis Diseases 0.000 description 1
- 241000722910 Burkholderia mallei Species 0.000 description 1
- 206010069747 Burkholderia mallei infection Diseases 0.000 description 1
- 241001136175 Burkholderia pseudomallei Species 0.000 description 1
- 206010069748 Burkholderia pseudomallei infection Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241001647378 Chlamydia psittaci Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 241000606678 Coxiella burnetii Species 0.000 description 1
- 241000223935 Cryptosporidium Species 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 208000006825 Eastern Equine Encephalomyelitis Diseases 0.000 description 1
- 201000005804 Eastern equine encephalitis Diseases 0.000 description 1
- 241000710945 Eastern equine encephalitis virus Species 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 206010014587 Encephalitis eastern equine Diseases 0.000 description 1
- 206010014611 Encephalitis venezuelan equine Diseases 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000711950 Filoviridae Species 0.000 description 1
- 241000589602 Francisella tularensis Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000224466 Giardia Species 0.000 description 1
- 201000003641 Glanders Diseases 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 206010023927 Lassa fever Diseases 0.000 description 1
- 241000712898 Machupo mammarenavirus Species 0.000 description 1
- 241001115401 Marburgvirus Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037151 Psittacosis Diseases 0.000 description 1
- 206010037688 Q fever Diseases 0.000 description 1
- 238000001530 Raman microscopy Methods 0.000 description 1
- 241000606697 Rickettsia prowazekii Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 208000034784 Tularaemia Diseases 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 208000002687 Venezuelan Equine Encephalomyelitis Diseases 0.000 description 1
- 201000009145 Venezuelan equine encephalitis Diseases 0.000 description 1
- 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000710951 Western equine encephalitis virus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229940074375 burkholderia mallei Drugs 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- MCMSPRNYOJJPIZ-UHFFFAOYSA-N cadmium;mercury;tellurium Chemical compound [Cd]=[Te]=[Hg] MCMSPRNYOJJPIZ-UHFFFAOYSA-N 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 239000002575 chemical warfare agent Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000001152 differential interference contrast microscopy Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 230000005274 electronic transitions Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229940118764 francisella tularensis Drugs 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 238000003706 image smoothing Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- WPYVAWXEWQSOGY-UHFFFAOYSA-N indium antimonide Chemical compound [Sb]#[In] WPYVAWXEWQSOGY-UHFFFAOYSA-N 0.000 description 1
- 238000003331 infrared imaging Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 238000003064 k means clustering Methods 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 238000011430 maximum method Methods 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 201000004015 melioidosis Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 238000001320 near-infrared absorption spectroscopy Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 201000000901 ornithosis Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 238000001907 polarising light microscopy Methods 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000009597 pregnancy test Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940046939 rickettsia prowazekii Drugs 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000005393 sonoluminescence Methods 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000000904 thermoluminescence Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 206010061393 typhus Diseases 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/44—Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/10—Arrangements of light sources specially adapted for spectrometry or colorimetry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/30—Measuring the intensity of spectral lines directly on the spectrum itself
- G01J3/32—Investigating bands of a spectrum in sequence by a single detector
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/21—Polarisation-affecting properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N2021/6417—Spectrofluorimetric devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N2021/6484—Optical fibres
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N2021/653—Coherent methods [CARS]
- G01N2021/656—Raman microprobe
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58471904P | 2004-06-30 | 2004-06-30 | |
| US10/882,082 US7046359B2 (en) | 2004-06-30 | 2004-06-30 | System and method for dynamic chemical imaging |
| US10/882,082 | 2004-06-30 | ||
| US60/584,719 | 2004-06-30 | ||
| US11/000,841 US7532320B2 (en) | 2004-06-30 | 2004-11-30 | Multimodal method for identifying hazardous agents |
| US11/000,841 | 2004-11-30 | ||
| PCT/US2005/023705 WO2006091223A2 (en) | 2004-06-30 | 2005-06-30 | Multimodal method for identifying hazardous agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2571932A1 true CA2571932A1 (en) | 2006-08-31 |
Family
ID=36927863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002571932A Abandoned CA2571932A1 (en) | 2004-06-30 | 2005-06-30 | Multimodal method for identifying hazardous agents |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1766351A4 (de) |
| CA (1) | CA2571932A1 (de) |
| WO (1) | WO2006091223A2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0606891D0 (en) | 2006-04-05 | 2006-05-17 | Council Cent Lab Res Councils | Raman Analysis Of Pharmaceutical Tablets |
| DE102006053540B3 (de) * | 2006-11-14 | 2008-01-31 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und Verfahren zur Analyse biologischer Proben |
| WO2008147227A1 (en) * | 2007-05-31 | 2008-12-04 | Veritide Limited | Method for spore detection |
| DE102007062067A1 (de) * | 2007-12-21 | 2009-07-02 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Optisches Verfahren und Vorrichtung zur Klassifizierung von Partikeln |
| CA2745796C (en) * | 2010-07-09 | 2018-11-06 | Niculae Mincu | Method and system for collecting optical data for use in time resolved optical imaging of a turbid media |
| CN103026191B (zh) | 2010-07-21 | 2015-08-19 | 第一太阳能有限公司 | 温度调整光谱仪 |
| GB201111560D0 (en) * | 2011-07-06 | 2011-08-24 | Micromass Ltd | Photo-dissociation of proteins and peptides in a mass spectrometer |
| FR2998967A1 (fr) * | 2012-12-03 | 2014-06-06 | Univ Lorraine | Appareil et methode de spectroscopie |
| EP2896957B1 (de) * | 2014-01-21 | 2017-11-15 | Molecular Devices, LLC | Monochromatorbasiertes Filter- und Detektionssystem |
| DE102015001033A1 (de) | 2015-01-27 | 2016-07-28 | Leibniz-Institut für Photonische Technologien e. V. | Hochdurchsatz-Screening-System zur Durchführung von optischen Messungen |
| KR20210094328A (ko) * | 2020-01-21 | 2021-07-29 | 삼성전자주식회사 | 대상체 인식 장치 및 그 동작 방법 |
| WO2024100252A1 (en) * | 2022-11-10 | 2024-05-16 | The European Union, Represented By The European Commission | A system for the detection of airborne viruses |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5442438A (en) * | 1988-12-22 | 1995-08-15 | Renishaw Plc | Spectroscopic apparatus and methods |
| US5638166A (en) * | 1995-05-18 | 1997-06-10 | The Regents Of The University Of California | Apparatus and method for rapid detection of explosives residue from the deflagration signature thereof |
| US5866430A (en) * | 1996-06-13 | 1999-02-02 | Grow; Ann E. | Raman optrode processes and devices for detection of chemicals and microorganisms |
| US5759859A (en) * | 1996-07-15 | 1998-06-02 | United States Of America As Represented By The Secretary Of The Army | Sensor and method for detecting trace underground energetic materials |
| EP1463926A4 (de) * | 2002-01-10 | 2010-09-08 | Chemimage Corp | Verfahren zur detektion pathogener mikroorganismen |
| US20040068193A1 (en) * | 2002-08-02 | 2004-04-08 | Barnes Russell H. | Optical devices for medical diagnostics |
-
2005
- 2005-06-30 WO PCT/US2005/023705 patent/WO2006091223A2/en active Search and Examination
- 2005-06-30 CA CA002571932A patent/CA2571932A1/en not_active Abandoned
- 2005-06-30 EP EP05857503A patent/EP1766351A4/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1766351A4 (de) | 2009-12-02 |
| EP1766351A2 (de) | 2007-03-28 |
| WO2006091223A2 (en) | 2006-08-31 |
| WO2006091223A3 (en) | 2007-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7532320B2 (en) | Multimodal method for identifying hazardous agents | |
| US6917423B2 (en) | Method for detection of pathogenic microorganisms | |
| US8094294B2 (en) | Multipoint method for identifying hazardous agents | |
| US7057721B2 (en) | Wide field method for detecting pathogenic microorganisms | |
| CA2571932A1 (en) | Multimodal method for identifying hazardous agents | |
| US10267734B2 (en) | Wavelength dispersive microscope spectrofluorometer for characterizing multiple particles simultaneously | |
| US7286222B2 (en) | Sample container and system for a handheld spectrometer and method for using therefor | |
| US7542138B2 (en) | Sample container and system for a handheld spectrometer and method for using therefor | |
| US7486395B2 (en) | System and method for a chemical imaging threat assessor with a probe | |
| US7436510B2 (en) | Method and apparatus for identifying a substance using a spectral library database | |
| CN101036038A (zh) | 用于识别有害制剂的多模式方法 | |
| WO2002063259A1 (en) | Systems and methods for filter based spectrographic analysis | |
| WO2006083316A2 (en) | Multipoint method for identifying hazardous agents | |
| US20130082180A1 (en) | Multipoint Method for Assessing a Biological Sample | |
| US20120252058A1 (en) | System and Method for the Assessment of Biological Particles in Exhaled Air | |
| US20120057743A1 (en) | System and method for fluorescence guided ingredient specific particle sizing | |
| US6552794B2 (en) | Optical detection method for improved sensitivity | |
| US20240053200A1 (en) | Detection and identification of body fluid traces with stand-off raman spectroscopy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |